PBA
Paradigm Biocapital Advisors Portfolio holdings
AUM
$2.34B
This Quarter Return
+21.59%
1 Year Return
+13.3%
3 Year Return
+245.82%
5 Year Return
–
10 Year Return
–
AUM
$852M
AUM Growth
+$852M
(+20%)
Cap. Flow
+$48M
Cap. Flow
% of AUM
5.64%
Top 10 Holdings %
Top 10 Hldgs %
62.79%
Holding
31
New
4
Increased
14
Reduced
5
Closed
8
Top Buys
| 1 |
SGEN
Seagen Inc. Common Stock
SGEN
|
$36.8M |
| 2 |
Vor Biopharma
VOR
|
$31.5M |
| 3 |
Arcellx
ACLX
|
$27.3M |
| 4 |
Biogen
BIIB
|
$23.3M |
| 5 |
Syndax Pharmaceuticals
SNDX
|
$22.1M |
Top Sells
| 1 |
GBT
Global Blood Therapeutics, Inc.
GBT
|
$80.1M |
| 2 |
Axsome Therapeutics
AXSM
|
$23.2M |
| 3 |
Ascendis Pharma
ASND
|
$17.7M |
| 4 |
Akero Therapeutics
AKRO
|
$12.5M |
| 5 |
Esperion Therapeutics
ESPR
|
$11.5M |
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
26
Esperion Therapeutics
ESPR
$490M
| – | – |
-1,719,831
| Closed | -$11.5M |
|
|
27
Axsome Therapeutics
AXSM
$6.09B
| – | – |
-520,080
| Closed | -$23.2M |
|
|
GBT
28
DELISTED
Global Blood Therapeutics, Inc.
GBT
| – | – |
-1,175,879
| Closed | -$80.1M |
|
|
OYST
29
DELISTED
Oyster Point Pharma, Inc. Common Stock
OYST
| – | – |
-1,648,316
| Closed | -$9.26M |
|
|
GTHX
30
DELISTED
G1 Therapeutics, Inc. Common Stock
GTHX
| – | – |
-884,574
| Closed | -$11M |
|
31
TG Therapeutics
TGTX
$5.03B
| – | – |
-1,505,479
| Closed | -$8.91M |
|